Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephen E. Fremes"'
Autor:
Jae K. Oh, G. Michael Deeb, G. Chad Hughes, Steven J. Yakubov, Stephen E. Fremes, Michael J. Reardon, Thomas G. Gleason, Stuart J. Head, Thomas Modine, Jian Huang, J. Kevin Harrison, M. Erwin Tan, Ka Yan Lam, Pim A.L. Tonino
Publikováno v:
The Annals of Thoracic Surgery. 113:616-622
Randomized clinical trials have shown that transcatheter aortic valve replacement is noninferior to surgery in low surgical risk patients. We compared outcomes in patients treated with a sutured (stented or stentless) or sutureless surgical valve fro
Autor:
Derrick Y. Tam, Maral Ouzounian, Rodolfo V. Rocha, Wanqing Yu, Ahmad Makhdoum, Stephen E. Fremes
Publikováno v:
Canadian Journal of Cardiology. 35:782-790
Aortic root enlargement (ARE) may be an important adjunct to aortic valve replacement (AVR) to prevent patient-prosthesis mismatch and facilitate future valve-in-valve transcatheter AVR (TAVR). However, the early safety and late benefits of adding su
Autor:
Jan O. Friedrich, Harindra C. Wijeysundera, Stephen E. Fremes, Danny Dvir, Thin Xuan Vo, Derrick Y. Tam
Publikováno v:
Catheterization and Cardiovascular Interventions. 92:1404-1411
Objective To determine the safety and efficacy of valve-in-valve transcatheter aortic valve replacement (ViV) versus redo surgical aortic valve replacement (SAVR) for the treatment of previously failed aortic bioprostheses. Background Valve-in-valve
Autor:
Derrick Y. Tam, Maral Ouzounian, Christoffer Dharma, Stephen E. Fremes, Harindra C. Wijeysundera, Rodolfo V. Rocha, Peter C. Austin
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 160:908-919.e15
Objective The safety and efficacy of aortic root enlargement (ARE) at the time of aortic valve replacement (AVR) remains unknown. The objective of this multicenter study was to compare AVR with ARE to AVR for early and late mortality and secondary sa
Publikováno v:
The Annals of thoracic surgery. 106(3)
Background A recent clinical trial showed that self-expandable transcatheter aortic valve replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However, the cost-effectiveness of self-expandable TAVR in the intermediate-ris
Autor:
Bernard S. Goldman, Naoji Hanayama, George T. Christakis, Campbell D. Joyner, Peter R.R Mitoff, Hari R. Mallidi, Christopher D. Morgan, Stephen E. Fremes
Publikováno v:
The Annals of thoracic surgery. 73(6)
Background . Although small valve size and patient-prosthesis mismatch are both considered to decrease long-term survival, little direct evidence exists to support this hypothesis. Methods . To assess the prevalence of patient-prosthesis mismatch and
Autor:
Richard D. Weisel, Vivek Rao, Karen J. Buth, Michael A. Borger, Stephen E. Fremes, George T. Christakis, Gideon Cohen, Bernard S. Goldman
Publikováno v:
The Annals of thoracic surgery. 66(4)
The sizes with which manufacturers label valves are nonuniform and haphazard. This has led to confusion and inappropriate comparisons of hemodynamics between valves with the same labeled size. Hemodynamic performance of valves is primarily determined